Lakeland Industries, Inc. — Form 10-Q Summary
Business Context and Reporting Period
Lakeland Industries manufactures and sells protective garments and accessories for industrial, governmental, homeland security, and emergency-response markets. This unaudited report covers the three and nine months ended October 31, 2014, representing Q3 FY2015. The company is a smaller reporting company with approximately 7.05 million common shares outstanding as of December 10, 2014.
Key Financial Metrics
| Metric | Three Months Ended October 31 | Nine Months Ended October 31 |
|---|---|---|
| Net sales | $25.1 million vs. $22.8 million | $73.2 million vs. $69.2 million |
| Gross profit | $8.6 million vs. $5.0 million | $23.8 million vs. $18.6 million |
| Gross margin | 34.3% vs. 22.1% | 32.5% vs. 26.9% |
| Operating profit | $0.7 million vs. $(1.0) million | $2.7 million vs. $0.03 million |
| Operating margin | 2.8% vs. (4.5%) | 3.8% vs. 0.1% |
| Net income (loss) | $(2.5) million vs. $(1.8) million | $(2.9) million vs. $1.5 million |
| Basic loss per share | $(0.42) vs. $(0.31) | $(0.49) vs. $0.27 |
Net loss for the quarter and year to date reflected a $2.3 million pretax charge for early extinguishment of subordinated debt, including approximately $1.6 million of remaining original issue discount and $0.6 million of unamortized financing fees. The company also recorded significant noncash stock-based compensation and related tax charges.
Operating cash flow was $3.2 million for the nine months ended October 31, 2014, compared with $(3.0) million in the prior-year period. Capital expenditures were $0.4 million. Cash and cash equivalents increased to $7.0 million from $4.6 million at January 31, 2014.
At October 31, 2014, working capital was approximately $45.5 million. The company had $5.1 million outstanding under its $15.0 million senior revolving facility and approximately $9.9 million of availability. The facility carried a 6.25% interest rate and matures in June 2016. Other obligations included $4.25 million remaining under the Brazil arbitration settlement, $3.36 million of long-term Brazil VAT taxes payable, short-term borrowings of $3.7 million, and $0.9 million of long-term Canada and Brazil loans.
Material Changes Versus Prior Comparable Period
- Third-quarter sales increased 10.1%, while nine-month sales increased 5.9%.
- U.S. sales benefited from increased demand for disposable and chemical protective products associated with the Ebola response. The company reported that disposable sales increased $1.9 million and chemical sales increased $0.8 million in the quarter.
- Gross margin improved substantially because of stronger product mix, normalized woven production, relocation of reflective production to Mexico, improved international margins, and better Brazilian operating performance.
- Operating expenses increased 30.3% in the quarter and 13.3% year to date, driven partly by commissions, additional personnel, foreign-currency effects, and a $1.0 million noncash charge related to the 2012 Restricted Stock Plan.
- On October 29, 2014, the company issued 1.11 million common shares at $10.00 per share, generating $11.1 million of gross proceeds and approximately $10.2 million net of fees. Proceeds were used primarily to repay the subordinated debt and temporarily reduce senior borrowings.
- The subordinated debt was fully repaid on October 29, 2014. The transaction eliminated future OID and financing-fee amortization but produced the one-time extinguishment charge.
- Brazil improved from a $1.9 million operating loss in the prior-year quarter to a $0.6 million loss, but remained materially unprofitable. Year-to-date Brazil operating loss was $1.2 million compared with $3.7 million previously.
Guidance, Outlook, Risks, and Unusual Items
Management did not provide formal full-year revenue or earnings guidance. It expected additional Ebola-related protective-product orders in the quarter ending January 31, 2015 and potentially thereafter, subject to the duration of the crisis and the company’s ability to secure orders. Management also expected FY2015 and FY2016 capital expenditures not to exceed $1.0 million per year.
Management planned to restructure Brazil by closing the Salvador facility, selling real estate and other assets, and potentially forming two new Brazilian entities in more favorable locations. The restructuring was expected between Q4 FY2015 and Q2 FY2016, but timing remained uncertain and a substantial pretax restructuring charge was anticipated.
- Management stated that liquidity, expected operating cash flow, and credit availability should be sufficient for the next 12 months, but covenant compliance depends on operating performance and other factors outside the company’s control.
- The company remained exposed to Brazil operating losses, foreign-exchange volatility, Brazilian VAT claims totaling approximately $7.3 million, and a separate approximately $1.0 million Brazilian tax claim for which no provision was recorded because management believed prevailing was probable.
- Four open Brazil VAT claims included one claim categorized as probable with an approximate total of $5.7 million; the company recorded $3.36 million as a long-term liability for the related principal and associated amounts.
- A Brazilian labor judgment of approximately $1.1 million was being appealed. The company recorded a $0.38 million charge based on its estimate of the ultimate outcome.
- Disclosure controls and internal control over financial reporting were not effective at October 31, 2014 because of material weaknesses involving China, Brazil, and entity-level oversight of foreign subsidiaries. Management reported remediation efforts but had not completed remediation.
- The company remained obligated to make $250,000 quarterly arbitration payments through December 31, 2018 and was current under the settlement.
Investor Verification Checklist
- Verify whether Ebola-related demand was temporary or translated into sustained sales and margins after FY2015.
- Track Brazil restructuring timing, restructuring charges, asset-sale proceeds, operating losses, VAT claims, and the labor judgment appeal.
- Confirm remediation of the China, Brazil, and entity-level internal-control material weaknesses.
- Monitor senior-credit-facility covenant compliance, borrowing-base availability, maturity, and interest expense.
- Reconcile the effects of the October 2014 equity issuance, debt repayment, warrant issuance, and resulting share dilution.
- Assess cash conversion, inventory levels, accounts receivable, and the company’s ability to fund international operations without violating lending restrictions.